MUC1 cytoplasmic tail detection using CT33 polyclonal and CT2 monoclonal antibodies in breast and colorectal tissue

Histology and Histopathology

Volumn 21, Issue 7-9, 2006, Pages 849-855

  Croce, M V ^a   Isla Larrain, M ^a   Remes Lenicov, F ^a   Colussi, A G ^a   Lacunza, E ^a   Kim, K C ^b   Gendler, S J ^c   Segal Eiras, Amada ^a  

^a UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^b UNIVERSITY OF MARYLAND   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

Breast cancer; CT2 monoclonal antibody; CT33 polyclonal antibody; MUC1 cytoplasmic tail

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CT2; MUCIN 1; POLYCLONAL ANTIBODY; POLYCLONAL ANTIBODY CT33; UNCLASSIFIED DRUG; CA 15-3 ANTIGEN; CANCER ANTIBODY; MONOCLONAL ANTIBODY MUC 1; MONOCLONAL ANTIBODY MUC-1; ORGANIC CATION TRANSPORTER; SLC22A16 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; BREAST CANCER; CELL FRACTIONATION; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION COEFFICIENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MOLECULAR WEIGHT; NONPARAMETRIC TEST; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING; BREAST; BREAST TUMOR; COLON; COLORECTAL TUMOR; ENZYME IMMUNOASSAY; HISTOLOGY; IMMUNOLOGY; METABOLISM; PATHOLOGY; RECTUM;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; BREAST; BREAST NEOPLASMS; CA-15-3 ANTIGEN; CELL FRACTIONATION; COLON; COLORECTAL NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; ORGANIC CATION TRANSPORT PROTEINS; RECTUM; TUMOR MARKERS, BIOLOGICAL;

EID: 33746116006     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Agrawal B., Gendler S. and Longenecker B. (1998). The biological role of mucins in cellular interactions and immune regulation: prospects for cancer immunotherapy. Mol. Med. Today 4, 397-403.
2. Ajioka Y., Allison L. and Jass J. (1996). Significance of MUC1 and MUC2 expression in colorectal cancer. J. Clin. Pathol. 49, 560-564.
3. Carrato C., Balague C., de Bolós C., González E., Gambas G., Planas J., Perini J., Andreu D. and Real F. (1994). Differential apomucin expression in normal and neoplastic human gastrointestinal tissues. Gastroenterology 107, 160-172.
4. Croce M., Colussi A., Price M. and Segal-Eiras A. (1997). Expression of tumour associated antigens in normal, benign and malignant human mammary epithelial tissue: a comparative immunohistochemical study. Anticancer Res. 17, 4287-92.
5. Croce M., Isla-Larrain M., Price M. and Segal-Eiras A. (2001). Detection of circulating mammary mucin (MUC1) and MUC1 immune complexes (MUC1-CIC) in healthy women. Int. J. Biol. Methods 16, 112-120.
6. Croce M., Isla-Larrain M., Rua C., Rabassa M., Gendler S. and Segal-Eiras A. (2003a). Patterns of MUC1 expression defined by an anticytoplasmic tail monoclonal antibody in breast cancer. J. Histochem. Cytochem. 51, 781-788.
7. Croce M.V., Isla-Larrain M., Demichelis S., Gori J., Price MR. and Segal-Eiras A. (2003b). Tissue and serum MUC1 mucin detection in breast cancer patients. Breast Cancer Res. Treat. 81, 195-207.
8. Devine P., McGuckin M., Ramm L., Ward B., Pee D. and Long S. (1993). Serum mucin antigens CASA and MSA in tumors of the breast, ovary lung, pancreas, bladder, colon and prostate. Cancer 72, 2007-2015.
9. Feickert H., Anger B., Cordón-Cardo C. and Lloyd K. (1990). Cell-surface antigens of human tumors detected by mouse monoclonal antibodies: definition of blood-group- and non-blood-group- related antigenic systems. Int. J. Cancer 46, 1007-1013.
10. Gendler S. (2001). MUC1, the renaissance molecule. J. Mammary Gland. Biol. Neoplasia 6, 339-353.
11. Gendler S., Lancaster C., Taylor-Papadimitriou J., Duhig T., Peat N., Burchell J., Pemberton L., Lalani E. and Wison D. (1990). Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J. Biol. Chem. 265, 15286-15293.
12. Griffiths A., Burchell J., Gendler S., Lewis A., Blight K., Tilly R. and Taylor-Papadimitriou J. (1987). Immunological analysis of mucin molecules expressed by normal and malignant epithelial cells. Int. J. Cancer 40, 319-327.
13. Harlow E. and Lane D. (1988). Antibodies: A laboratory manual, Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY.
14. Laemmli U. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
15. Li Y., Bharti A., Chen D., Gong J. and Kufe D. (1998). Interaction of glycogen synthase 3 β, with DF3/MUC1 carcinoma-associated antigen and β-catenin. Mol. Cell. Biol. 18, 7216-7224.
16. Li Y. and Kufe D. (2001). The human DF3/MUC1 carcinoma associated antigen signals nuclear localization of the catenin 120ctn. Biochem. Biophys. Res. Commun. 281, 440-443.
17. Li Y., Kuwahara H., Ren J., Wen G. and Kufe D. (2001a). The c-Src tyrosine kinase regulates signalling of the human DF3/MUC1 carcinoma-associated antigen with GSK3, and β-catenin. J Biol Chem 276, 6061-6064.
18. Li Y., Ren J., Yu W., Li Q., Kuwahara H., Yin L., Carraway K., Kufe D. (2001c). The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and β-catenin. J. Biol. Chem. 276, 35239-35242.
19. Ligtenberg M., Vos H., Gennissen A. and Hilkens J. (1990). Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini. J. Biol. Chem 265, 5573-5578.
20. Linsley P., Brown J., Mangani J. and Horn D. (1998). Monoclonal antibodies reactive with mucin glycoproteins found in sera from breast cancer patients. Cancer Res. 48, 2138-2148.
21. Luna-Moré S., Rius F., Weil B., Jiménez A., Bautista M. and Pérez-Mellado A. (2001). EMA: a differentiation antigen related to node metastatic capacity of breast carcinomas. Pathol. Res. Pract. 197, 419-425.
22. Meerzaman D., Shapiro P. and Kim K. (2001). Involvement of the MAP kinase ERK2 in Muc1 mucin signaling. Am. J. Physiol. (Lung Cell Mol Physiol) 281, L86-91.
23. Pandey P., Kharbanda S. and Kufe D. (1995). Association of DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein. Cancer Res. 55, 4000-4003.
24. Price M., Edwards S., Owainati A., Bullock J., Ferry B., Robins R. and Baldwin R. (1985). Multiple epitopes on a human breast associated antigen. Int. J. Cancer 36, 567-574.
25. Price M., Pugh J., Hudecz F., Griffiths W., Jacobs E., Symonds I., Clarke A., Chan W. and Baldwin R. (1990). C595-a monoclonal antibody against the protein core of human urinary epithelial mucin commonly expressed in breast carcinomas. Br. J. Cancer 61, 681-686.
26. Rahn J., Dabbagh L., Pasdar M. and Hugh J. (2001). The importance of MUC1 localization in patients with breast cancer: an immunological study 71 patients and review of the literature. Cancer 91, 1973-1982.
27. Ren J., Li Y. and Kufe D. (2002). Protein kinase C delta regulates function of the DF3/MUC1 carcinoma antigen in beta-catenin signaling. J. Biol. Chem. 277, 17616-17622.
28. Renkonen J., Pavoneen T. and Renkonen R. (1997). Endotelial and epithelial expression of sialyl Lewis x and sialil Lewis in lesions of breast carcinoma. Int. J. Cancer 74, 296-300.
29. Schroeder J., Thompson M., Gardner M. and Gendler S. (2001). Transgenic MUC1 interacts with EGFR and correlates with MAP kinase activation in mouse mammary gland. J. Biol. Chem. 276, 13057-13064.
30. Spicer A., Duhig T., Chilton B. and Gendler S. (1995). Analysis of mammalian MUC1 genes reveals potential functionally important domains. Mamm. Genome 6, 885-888.
31. Towbin H., Staehelin T. and Gordon J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350-4354.
32. Wang H., Lillehof E. and Kim K. (2003). Identification of four sites of stimulated tyrosine phosphorylation in the MUC1 cytoplasmic tail. Biochem. Biophys. Res. Commun. 310, 341-346.
33. Wen Y., Caffrey T., Wheelock M., Johnson K. and Hollingsworth M. (2003). Nuclear association of the cytoplasmic tail of MUC1 and beta-catenin. J. Biol. Chem. 278, 8029-8039.
34. Winterford C., Walsh M., Leggett B. and Jass J. (1999). Ultraestructural localization of epithelial mucin core proteins in colorectal tissues. J Histochem. Cytochem. 47, 1063-1074.
35. Yamamoto M., Bharti A., Li Y. and Kufe D. (1997). Interaction of the DF3/ MUC1 breast carcinoma-associated antigen and β-catenin in cell adhesion. J. Biol. Chem. 272, 12492-12494.